Agios Pharmaceuticals, Inc. · NASDAQ:AGIO

Paradigm Biocapital Advisors LP reported a 5.20% stake in Agios Pharmaceuticals, Inc. (Schedule 13G)

Event Aug 21, 2025 · Filed Aug 28, 2025

Paradigm Biocapital Advisors LP reported a 5.20% stake in Agios Pharmaceuticals, Inc., 3,027,977 shares, as a passive investor on Aug 21, 2025. Filed Aug 28, 2025 (Schedule 13G).

Stake
5.20%
Shares
3,027,977
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Paradigm BioCapital Advisors LP5.20%3,027,977
Paradigm BioCapital Advisors GP LLC5.20%3,027,977
Senai Asefaw, M.D.5.20%3,027,977
Paradigm BioCapital International Fund Ltd.4.60%2,669,945

Source

View original at SEC

Related